Bellevue Life Sciences Ac... (BLAC)
NASDAQ: BLAC
· Real-Time Price · USD
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
Bellevue Life Sciences Acquisition Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Net Income | -2.02M | -230.96K | -97.3K | -60.43K | -86.17K | 78.18K | 301.46K | 110.31K | -14.25K | -20.02K | -988 | -126 | -322 | -119 |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -288.8K | 147.19K | -357.87K | 499.47K | 735.44K | 163.22K | 161.22K | -81.07K | 13.3K | 23.81K | n/a | n/a | 201.00 | 5.29K |
Other Non-Cash Items | 1.52M | -350.02K | -465.5K | -480.82K | -928.76K | -618.5K | -810.3K | -417.73K | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 354.11K | -853.58K | 499.47K | 735.44K | 397.09K | 161.22K | 259K | 13.3K | 23.81K | -5.96K | n/a | 201.00 | 5.29K |
Operating Cash Flow | -502.91K | -226.88K | -1.42M | -41.78K | -279.49K | -143.23K | -347.62K | -48.43K | -952 | 3.79K | -6.95K | -126 | -121 | 5.17K |
Capital Expenditures | n/a | 2.00 | -2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | 280K | -160K | -120K | -180K | n/a | n/a | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 36.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 18.97M | -430K | 17.36M | -120K | 36.38M | n/a | n/a | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 18.97M | -150K | 17.2M | -120K | 36.38M | n/a | n/a | -70.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | -1.78M | 280K | 1.36M | 135K | -145K | 200K | n/a | -1.2M | 300K | -7K | 400K | 100K | 10K | 100K |
Common Stock Repurchased | n/a | 17.05M | -17.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.2M | -10K | 10K | 15K | n/a | n/a | n/a | 7.71M | -243.38K | 7K | -335.27K | -88.24K | -14.13K | -106.3K |
Financial Cash Flow | -18.42M | 270K | -15.67M | 150K | -36.14M | 200K | n/a | 70.48M | 56.62K | -9.13K | 64.73K | 11.76K | -4.13K | -6.3K |
Net Cash Flow | 53.9K | -106.88K | 115.48K | -11.78K | -42.54K | 56.77K | -347.62K | 224.3K | 55.67K | -5.34K | 57.78K | 11.63K | -4.25K | -6.42K |
Free Cash Flow | -502.91K | -226.88K | -1.42M | -41.78K | -279.49K | -143.23K | -347.62K | -48.43K | -952 | 3.79K | -6.95K | -126 | -121 | 5.17K |